Related Experiment Video
Updated: Oct 18, 2025
11:19
Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
17.8K
Update to the Minimum Requirements for Core Competency in Pediatric Hospital Pharmacy Practice
Summary
Pharmacy schools vary in pediatric therapeutics education, impacting new graduates' readiness for pediatric patient care. The Pediatric Pharmacy Association updated its competencies to ensure consistent pharmacist expertise for hospitalized children.
Area of Science:
- Pharmacology
- Pediatric Therapeutics
- Pharmacy Education
Background:
- Colleges of pharmacy offer inconsistent didactic and clinical hours in pediatric therapeutics.
- This variability leads to diverse knowledge, skills, and perceptions among new pharmacy graduates regarding pediatric patient care.
- The Pediatric Pharmacy Association (PPA) advocates for standardized core competencies for pharmacists caring for pediatric patients.
Discussion:
- The PPA's updated 2015 Position Statement addresses the need for consistent training.
- Ensuring a minimum set of core competencies is crucial for pharmacists working with hospitalized children of all ages.
- Standardization aims to improve the quality and safety of pediatric pharmaceutical care.
Key Insights:
- Varied educational experiences create disparities in new pharmacists' preparedness for pediatric practice.
- A unified approach to pediatric pharmacy education is essential for patient safety.
- The PPA's updated guidelines provide a benchmark for essential pediatric pharmacy skills.
Outlook:
- Future efforts should focus on harmonizing pediatric pharmacy curricula across institutions.
- Continuous evaluation and updates to core competencies will be necessary to meet evolving pediatric healthcare needs.
- Implementing standardized training can enhance pharmacist confidence and competence in pediatric care.
More Related Videos
09:30Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
3.8K
11:27A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
Published on: April 7, 2023
6.8K
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
37
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
37
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
37
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
37
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
31
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
31
01:29Drug Dosing: Infants and Children
46
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
46
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
35
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
35
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
25
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
25